DERM News and Press, Journey Medical Corporation From 05/13/25

2025-05-13 18:48:09 ET Journey Medical Corporation (DERM) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 4.40%. The average open to low on the day of earnings was -7.81%. The average op...

2025-05-13 18:43:09 ET Journey Medical Corporation (DERM) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in DERM stock price following earnings has averaged ±2.51% , with a median of 1.0...

SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA...

2025-04-25 11:31:47 ET Journey Medical Corporation (NASDAQ: DERM) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 0.66% on the day to $7.61. Journey Medical Corporation focuses on the development and commercialization of pharmaceutical pro...

2025-04-23 09:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-04-08 16:10:00 ET Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major underlying drivers — higher rates of cancer and chronic di...

2025-04-07 10:44:13 ET Shares of Journey Medical Corporation (NASDAQ: DERM) traded at a new 52-week high today and are currently trading at $6.65. So far today, approximately 107.92k shares have been exchanged, as compared to an average 30-day volume of 76,565 shares. Journey Medica...

2025-04-01 16:06:29 ET More on Journey Medical Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript Journey Medical: FDA Approval For Emrosi Makes This An Exciting Stock Journey Medical Corporation: Emrosi's Launch Could Be A Turning Point Seek...

SCOTTSDALE, Ariz., April 01, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (&#...

2025-03-26 19:10:04 ET Journey Medical Corporation (DERM) Q4 2024 Results Conference Call March 26, 2025 04:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founder, President and CEO Joseph Benesch - Chief Fi...